Quarter Comparison
Revenue
Operating Income
Net Margin
Free Cash Flow
Income Statement
Cash Flow Statement
Balance Sheet
Operating metrics disclosed this quarter
Read from the filing itself — XBRL does not carry these, so no standard financial dataset has them.
Remaining Performance Obligations
$10.70B
Revenues - Products and Services As of June 30, 2026 and December 31, 2025, accounts receivable related to products and services were $ 9.5 billion and $ 9.7 billion, respectively. As of June 30, 2026, revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, was $ 10.7 billion, of which more than half is expected to be recognized in the next three years .
Medical Care Ratio
86.7%
The following table summarizes our consolidated results of operations and other financial information: (in millions, except percentages and per share data) | | | Three Months Ended June 30, | | | Increase/ (Decrease) | | | Six Months Ended June 30, | | | Increase/ (Decrease) 2026 | | | 2025 | | | 2026 vs. 2025 | | | 2026 | | | 2025 | | | 2026 vs. 2025 Revenues: Premiums | | | $ | | 86,956 | | | | $ | | 87,905 | | | | $ | | (949) | | | | (1) | | % | | | $ | | 174,517 | | | | $ | | 174,439 | | | | $ | | 78 | | | | — | | % Products | | | 13,835 | | | | 13,564 | | | | 271 | | | | 2 | | | | 27,085 | | | | 26,600 | | | | 485 | | | | 2 Services | | | 10,018 | | | | 9,039 | | | | 979 | | | | 11 | | | | 19,797 | | | | 18,011 | | | | 1,786 | | | | 10 Investment and other income | | | 1,223 | | | | 1,108 | | | | 115 | | | | 10 | | | | 2,354 | | | | 2,141 | | | | 213 | | | | 10 Total revenues | | | 112,032 | | | | 111,616 | | | | 416 | | | | — | | | | 223,753 | | | | 221,191 | | | | 2,562 | | | | 1 Operating costs: Medical costs | | | 75,358 | | | | 78,585 | | | | (3,227) | | | | (4) | | | | 148,847 | | | | 151,996 | | | | (3,149) | | | | (2) Operating costs | | | 14,268 | | | | 13,778 | | | | 490 | | | | 4 | | | | 29,658 | | | | 27,372 | | | | 2,286 | | | | 8 Cost of products sold | | | 13,375 | | | | 13,019 | | | | 356 | | | | 3 | | | | 26,198 | | | | 25,409 | | | | 789 | | | | 3 Depreciation and amortization | | | 1,040 | | | | 1,084 | | | | (44) | | | | (4) | | | | 2,069 | | | | 2,145 | | | | (76) | | | | (4) Total operating costs | | | 104,041 | | | | 106,466 | | | | (2,425) | | | | (2) | | | | 206,772 | | | | 206,922 | | | | (150) | | | | — Earnings from operations | | | 7,991 | | | | 5,150 | | | | 2,841 | | | | 55 | | | | 16,981 | | | | 14,269 | | | | 2,712 | | | | 19 Interest expense | | | (962) | | | | (1,027) | | | | 65 | | | | (6) | | | | (1,917) | | | | (2,025) | | | | 108 | | | | (5) Loss on sale of subsidiary and subsidiaries held for sale | | | (61) | | | | (41) | | | | (20) | | | | 49 | | | | (133) | | | | (56) | | | | (77) | | | | 138 Earnings before income taxes | | | 6,968 | | | | 4,082 | | | | 2,886 | | | | 71 | | | | 14,931 | | | | 12,188 | | | | 2,743 | | | | 23 Provision for income taxes | | | (1,298) | | | | (510) | | | | (788) | | | | 155 | | | | (2,780) | | | | (2,142) | | | | (638) | | | | 30 Net earnings | | | 5,670 | | | | 3,572 | | | | 2,098 | | | | 59 | | | | 12,151 | | | | 10,046 | | | | 2,105 | | | | 21 Earnings attributable to noncontrolling interests | | | (186) | | | | (166) | | | | (20) | | | | 12 | | | | (387) | | | | (348) | | | | (39) | | | | 11 Net earnings attributable to UnitedHealth Group common shareholders | | | $ | | 5,484 | | | | $ | | 3,406 | | | | $ | | 2,078 | | | | 61 | | % | | | $ | | 11,764 | | | | $ | | 9,698 | | | | $ | | 2,066 | | | | 21 | | % Diluted earnings per share attributable to UnitedHealth Group common shareholders | | | $ | | 6.04 | | | | $ | | 3.74 | | | | $ | | 2.30 | | | | | | $ | | 12.94 | | | | $ | | 10.61 | | | | $ | | 2.33 Medical care ratio (a) | | | 86.7 | | % | | | 89.4 | | % | | | (2.7) | | % | | | | | 85.3 | | % | | | 87.1 | | % | | | (1.8) | | % Operating cost ratio | | | 12.7 | | | | 12.3 | | | | 0.4 | | | | | | 13.3 | | | | 12.4 | | | | 0.9 Operating margin | | | 7.1 | | | | 4.6 | | | | 2.5 | | | | | | 7.6 | | | | 6.5 | | | | 1.1 Tax rate | | | 18.6 | | | | 12.5 | | | | 6.1 | | | | | | 18.6 | | | | 17.6 | | | | 1.0 Net earnings margin (b) | | | 4.9 | | | | 3.1 | | | | 1.8 | | | | | | 5.3 | | | | 4.4 | | | | 0.9 Return on equity (c) | | | 22.3 | | % | | | 14.4 | | % | | | 7.9 | | | | | | 24.3 | | % | | | 20.6 | | % | | | 3.7 (a) Medical care ratio (MCR) is calculated as medical costs divided by premium revenue.
Earnings Release
EX-99.1 2 earningsrelease2q26_7152.htm EX-99.1 earningsrelease2q26_7152 Page 1 of 17 UnitedHealth Group Reports Second Quarter 2026 Results • Second Quarter 2026 Revenues of $112.0 Billion; Earnings from Operations of $8.0 Billion • Earnings of $6.04 Per Share and Adjusted Earnings of $6.38 Per Shar
EX-99.1 2 earningsrelease2q26_7152.htm EX-99.1 earningsrelease2q26_7152 Page 1 of 17 UnitedHealth Group Reports Second Quarter 2026 Results • Second Quarter 2026 Revenues of $112.0 Billion; Earnings from Operations of $8.0 Billion • Earnings of $6.04 Per Share and Adjusted Earnings of $6.38 Per Share • Updated Full Year 2026 Earnings Outlook Range to $18.45 to $18.95 Per Share; Adjusted Earnings Range of $19.50 to $20.00 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-reports-second-quarter-2026-results.pdf (July 16, 2026) UnitedHealth Group (NYSE: UNH) today reported second quarter 2026 results and raised guidance for full year 2026. “Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both afford...
Source
Exhibit EX-99.1
0000731766-26-000191
Filed July 16, 2026 at 10:00 AM UTC. The figures above are from the audited statements, not from this release.